Investor Presentation for quarter ended on June 30 2026

SEPL/SE/August/26-27 08th August 2026 The General Manager, The Manager, Corporate Relations/Listing Listing Department Department National Stock Exchange of India Limited BSE Limited Exchange Plaza, Plot No. C/1, G Block, Floor 25, P.J. Towers, Bandra – Kurla Complex, Dalal Street, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 501423 Scrip Code: SHAILY Sub: Q1 & FY27 – Investor Presentation Ref: Regulation 30 of the SEBI Listing Regulations, 2015 Dear Sir, In continuation to our letter dated 03rd August 2026, regarding intimation of Earnings Call of the Company scheduled on Monday, 10th August 2026 at 04:00 p.m., IST, to discuss the operational & financial performance of the Company for the quarter ended on 30th June 2026, kindly find enclosed herewith Q1 & FY27 Investor Presentation of the Company. A copy of the same is also available on our website www.shaily.com. Kindly take the same on record. Thanking You. Yours truly, For Shaily Engineering Plastics Limited Harish Punwani Company Secretary & Compliance Officer M.No. A 50950 Encl: a/a Shaily Engineering Plastics Ltd. Investor Presentation August 2026 Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Shaily Engineering Plastics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party statements and projections. Key Performance Highlights Business Updates for Q1 FY27 Healthcare Consumer Industrial Semaglutide pens supply by Business confirmation Business confirmation the company received for received for • Customer approvals • Global project from FMCG • New project from received for Semaglutide customer Appliance customer in Canada / Brazil • New projects from • Five parts for new • Two new projects signed customer in LED lights consumer in Consumer for IP led platforms Electronics • New project from Automotive customer Key Consolidated Financial Highlights – Q1 FY27 Revenues Gross Profit Margin EBITDA +14% +540 bps +18% 280.7 56.6% 83.3 246.7 51.2% 70.4 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 EBITDA Margins Profit After Tax Cash PAT# +120 bps +17% +18% 28.5% 29.7% 48.0 62.1 41.1 52.6 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 (Rs. Cr.) #Cash PAT includes PAT + Depreciation * Includes the UK & UAE Subsidiary Business 5 Segment Wise Revenue Breakup Revenue (Consumer) Revenue (Healthcare) Revenue (Industrial) TOTAL REVENUE Weaker Market Demand for Home Furnishings across Europe & USA +85% +25% +14% -24% 142.4 22.7 280.7 151.4 246.7 18.1 115.5 77.2 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Q1FY26 Q1FY27 Improved traction in the healthcare segment has been the key driver for the overall growth of the business On Consolidated Basis 6 Operational Trends Revenue Analysis – Domestic vs. Exports +150 bps 50.2% 48.7% The shift in the domestic-export mix is primarily due to the growing Healthcare business, where supplies to Indian pharma customers ultimately cater to global markets. i t( Q1 FY26 Q1 FY27 n s 23.9% 41.9% MA vs. 58.1% 76.1% Export Domestic Q1FY26 Q1FY27 On Consolidated Basis 7 Efficient Use of Capital RoCE RoE Fixed Asset Turnover Total Debt / Equity +320 bps +130 bps 39.0% 28.2% 1.9 0.3 26.9% 35.8% Mar-26 Jun-26* Mar-26 Jun-26* Mar-26 Jun-26* Mar-26 Jun-26 On Consolidated Basis; *On Annualized basis 8 Consolidated Profit & Loss Statement Particulars (Rs. Crs.) Q1FY27 Q1FY26 YoY Change Revenue 280.7 246.7 +14% Raw Material 121.8 120.5 Employee Expenses 32.8 24.9 Other Expenses* 43.0 33.0 Other Income 0.3 2.1 EBITDA 83.3 70.4 +18% EBITDA Margin 29.7% 28.5% +120 bps Depreciation 14.0 11.4 Finance Cost 3.3 3.9 PBT 65.9 55.1 +20% PBT Margin 23.5% 22.3% +120 bps Tax 17.9 14.0 PAT 48.0 41.1 +17% PAT Margin 17.1% 16.7% +40 bps Cash PAT^ 62.1 52.6 +18% Cash PAT Margin 22.1% 21.3% +80 bps * Other Expenses include Power & Fuel costs; ^ Cash PAT = PAT + Depreciation 9 About the Company Enriching Lives Through Plastics Shaily Engineering Plastics Limited is India’s largest exporter of plastics components. Established in 1987, the Company provides end-to-end solutions in plastic products and services, whilst delivering superior quality and value to all stakeholders. Founded The Company employs over 2,000+ employees and have over 1987 200+ injection molding machines, with precise, high speed automated and robotic production lines. 7 Facilities in Revenue* Long-standing Gujarat Rs. 991 Crores global relationships 6 for Plastic FY 26 with marquee clients 1 for Steel Furniture 200+ Over De-risked Injection moulding 2,000 employees Business Model machines across 7 plants On Consolidated Basis 10 Business Segments Consumer Industrial Healthcare ✓ Automotive Components ✓ Appliances ✓ Platform Devices ✓ LED Lights ✓ Home Furnishings ✓ High-Performance Engineering ✓ Drug Delivery Devices ✓ Toys ✓ FMCG Packaging Components ✓ Pharma Packaging ✓ Carbon Steel Furniture ✓ Consumer Electronics ✓ Semiconductor Trays and Packaging State-of-the-Art Manufacturing Facilities 7 Facilities with over 200 molding machines ranging from 35 tons to 1,000 tons Rania ❖ Export Oriented Unit ❖ Pharma (Dedicated ISO Class 8 clean room manufacturing facility) ❖ Others Rania Halol Halol (GIDC) GUJARAT ❖ Automotive & Engineering Halol ❖ Carbon Steel ❖ Plastic Maps not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness. 12 Board of Directors Executive Chairman Whole Time Director Managing Director Mr. Mahendra Sanghvi Mrs. Tilottama Sanghvi Mr. Amit Sanghvi Independent Director Independent Director Executive Director Mr. Ranjit Singh Dr. Shailesh Ayyangar Mr. Laxman Sanghvi In [Showing first 8,000 characters — download PDF for full document]